Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with DTPa vaccine in Japanese children: A randomized, controlled study.
Iwata S, Kawamura N, Kuroki H, Tokoeda Y, Miyazu M, Iwai A, Oishi T, Sato T, Suyama A, François N, Shafi F, Ruiz-Guiñazú J, Borys D. Iwata S, et al. Among authors: kawamura n. Hum Vaccin Immunother. 2015;11(4):826-37. doi: 10.1080/21645515.2015.1012019. Hum Vaccin Immunother. 2015. PMID: 25830489 Free PMC article. Clinical Trial.
Nationwide survey of the development of drug resistance in the pediatric field in 2007 and 2010: drug sensitivity of Haemophilus influenzae in Japan (second report).
Hoshino T, Sato Y, Toyonaga Y, Hanaki H, Sunakawa K; Drug-Resistant Pathogen Surveillance Group in Pediatric Infectious Disease. Hoshino T, et al. J Infect Chemother. 2013 Jun;19(3):495-503. doi: 10.1007/s10156-013-0591-z. Epub 2013 Apr 7. J Infect Chemother. 2013. PMID: 23564330 Free PMC article.
Nationwide surveillance of bacterial pathogens isolated from children conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2017: General overview of pathogenic antimicrobial susceptibility.
Ishiwada N, Fujimaki K, Matsumoto T, Kiyota H, Tateda K, Sato J, Hanaki H, Takayanagi R, Yamaguchi Y, Hoshino T, Kuroki H, Iwata S, Tajima T, Horikoshi Y, Shiro H, Bamba M, Kawamura N, Ouchi K, Matsubara K, Okada T, Furuno K, Tsumura N. Ishiwada N, et al. Among authors: kawamura n. J Infect Chemother. 2021 Feb;27(2):139-150. doi: 10.1016/j.jiac.2020.11.020. Epub 2020 Dec 1. J Infect Chemother. 2021. PMID: 33277177
Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.
Morozumi M, Hasegawa K, Kobayashi R, Inoue N, Iwata S, Kuroki H, Kawamura N, Nakayama E, Tajima T, Shimizu K, Ubukata K. Morozumi M, et al. Among authors: kawamura n. Antimicrob Agents Chemother. 2005 Jun;49(6):2302-6. doi: 10.1128/AAC.49.6.2302-2306.2005. Antimicrob Agents Chemother. 2005. PMID: 15917525 Free PMC article.
A practical approach estimating etiologic agents using real-time PCR in pediatric inpatients with community-acquired pneumonia.
Okada T, Morozumi M, Sakata H, Takayanagi R, Ishiwada N, Sato Y, Oishi T, Tajima T, Haruta T, Kawamura N, Ouchi K, Matsubara K, Chiba N, Takahashi T, Iwata S, Ubukata K. Okada T, et al. Among authors: kawamura n. J Infect Chemother. 2012 Dec;18(6):832-40. doi: 10.1007/s10156-012-0422-7. Epub 2012 May 9. J Infect Chemother. 2012. PMID: 22569795 Clinical Trial.
1,123 results